Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:56 AM
Ignite Modification Date:
2025-12-25 @ 2:56 AM
NCT ID:
NCT02916433
Eligibility Criteria:
Inclusion Criteria:
* Patients are being weaned from mechanical ventilation
* Excessive bronchial secretions (over 200 ml/24 hours) is deemed by the Primary Team to be a major barrier to extubation
Exclusion Criteria:
* Known hypersensitivity to octreotide
* Persistent bradycardia (HR \< 60)
* Mobitz type II or 3rd degree heart block in patients without a pacemaker
* Patients being treated with intravenous agents for hypertensive urgency or emergency
* Surgical patients
* Initiation of therapy with systemic or inhaled steroids within 72 hours prior to the enrollment into the study, as these may further change the rate of secretions\*
* Initiation of therapy with systemic or inhaled anticholinergics within 48 hours prior to the enrollment into the study, as these may further change the rate of secretions
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02916433
Study Brief:
Protocol Section:
NCT02916433